+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Targeted Genome Analysis Kits Market - Global Forecast 2026-2032- Product Image
Targeted Genome Analysis Kits Market - Global Forecast 2026-2032- Product Image
New

Targeted Genome Analysis Kits Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 180 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6122186
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The targeted genome analysis kits market is evolving amid rapid technology advancements and operational challenges, compelling life sciences stakeholders to rethink kit design, procurement, and deployment. As clinical, academic, and industrial buyers navigate heightened performance expectations, the need for robust, integrated solutions becomes increasingly clear.

Market Snapshot: Targeted Genome Analysis Kits

The targeted genome analysis kits market grew from USD 2.89 billion in 2025 to USD 3.06 billion in 2026 and is projected to reach USD 4.48 billion by 2032, reflecting a CAGR of 6.46%. This expansion is driven by the intersection of technological maturity, clinical demand, and evolving supply chain dynamics, with suppliers and end-users adapting strategies for sustained growth.

Scope & Segmentation

  • Product Types: Next Generation Sequencing Kits (Amplicon, Exome, Whole Genome), Sanger Sequencing Kits (Capillary, Dideoxy), qPCR Kits (Dye: EvaGreen, Sybr Green; Probe: Molecular Beacon, TaqMan), Microarray Kits (DNA: Comparative Genomic Hybridization, SNP Genotyping; RNA: Expression Profiling, miRNA), and Hybridization Kits (FISH: Direct and Indirect Labeling, Microchip, Southern Blot)
  • Applications: Basic research, diagnostic workflows, rare variant detection, transcriptome profiling, and decentralised testing
  • End Users: Academic research laboratories, clinical diagnostic centers, industrial R&D teams
  • Technologies: Sequencing chemistry advancements, high-fidelity amplification, qPCR innovation, advanced hybridization specificity
  • Regions: Americas (robust research, large diagnostics sector), Europe, Middle East & Africa (diverse infrastructure, regulatory complexity), Asia-Pacific (fast adoption, local manufacturing, increasing technical validation requirements)

Key Takeaways for Senior Decision-Makers

  • Technical improvements in sequencing throughput and accuracy are opening new use cases, with rare variant detection and transcriptomic analysis extending the utility of targeted genome analysis kits.
  • Operational needs prioritize automation compatibility, ease of use, and instrument interoperability, which help reduce validation time and lower barriers to adoption in both clinical and research settings.
  • Manufacturers are responding with modular architectures, robust quality management, and co-development partnerships, ensuring kit designs align with evolving regulatory, performance, and logistical requirements.
  • Buyers and procurement teams are demanding resilience—both in supplier reliability and logistics—leading to expanded sourcing matrices, regional manufacturing, and buffer inventories for sensitive reagents.
  • The ecosystem is trending toward integrated product-service packages that include validation support, digital enablement, and lifecycle management, all accelerating adoption and embedding value in laboratory workflows.

Tariff Impact on Sourcing and Operations

Current tariff-driven trade measures are prompting procurement leaders to diversify supplier networks, reevaluate sourcing models, and increase buffer inventories. Decisions now weigh commercial terms and supplier risk profiles more carefully, as facilities adjust to fluctuating lead times and potential cost volatility. Manufacturers are also leveraging regional manufacturing, local partnerships, and flexible shipping strategies, ensuring continuity despite shifting policy landscapes.

Primary Keyword: Targeted Genome Analysis Kits

Segmentation Addresses Diverse Scientific Workflows

Distinct kit segments address workflows in sequencing, qPCR, microarray, and hybridization, each with dedicated validation requirements and instrument compatibility factors. These specialized pathways drive product format decisions and commercialization tactics, matching laboratory needs for flexibility, documentation, and technical support.

Methodology & Data Sources

This report is built on primary interviews with laboratory directors, procurement leads, and R&D managers alongside in-depth analyses of protocols, validation studies, and regulatory documents. Stakeholder perspectives, manufacturer documentation, and cross-validated performance claims inform the recommendations, with methodological transparency and acknowledgment of regional workflow variations. Where regulatory differences or workflow inconsistencies were detected, triangulation ensured balanced conclusions.

Why This Report Matters

  • Provides insights for sourcing leaders and product strategists seeking to optimize procurement, manage supply chain resilience, and align commercialization with regional dynamics.
  • Clarifies how technology and operational priorities intersect to drive measurable differentiation and a clear path from technical validation to clinical or industrial deployment.
  • Illustrates strategies for vendors and decision-makers to convert technical advancements into scalable, defensible market positions, strengthening long-term partnerships across diverse laboratory settings.

Conclusion

The targeted genome analysis kits sector is being shaped by simultaneous advances in technology, regulation, and supply chain strategy. Senior stakeholders who align product engineering, operational agility, and service value will sustain growth and relevance in a demanding, dynamic market environment.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Targeted Genome Analysis Kits Market, by Target Type
8.1. DNA
8.1.1. Germline DNA
8.1.2. Somatic DNA
8.1.3. Mitochondrial DNA
8.2. RNA
8.2.1. mRNA
8.2.2. Non-Coding RNA
8.2.3. Fusion Transcripts
8.3. Epigenetic Marks
8.3.1. DNA Methylation
8.3.2. Chromatin Accessibility
9. Targeted Genome Analysis Kits Market, by Product Type
9.1. Complete Kits
9.1.1. Library Preparation Kits
9.1.2. Target Enrichment Kits
9.1.3. Integrated Library and Enrichment Kits
9.2. Panel-Only Reagent Sets
9.3. Accessories and Controls
9.3.1. Indexing and Barcoding Kits
9.3.2. Reference Standards and Controls
9.3.3. Cleanup and Size Selection Reagents
9.4. Software and Analytics Bundles
9.4.1. Data Analysis Software Licenses
9.4.2. Interpretation and Reporting Tools
9.4.3. Cloud-Based Analysis Services
10. Targeted Genome Analysis Kits Market, by Application Area
10.1. Oncology
10.1.1. Solid Tumor Oncology
10.1.2. Hematologic Oncology
10.1.3. Minimal Residual Disease Monitoring
10.2. Inherited and Rare Disease
10.3. Reproductive Health
10.3.1. Carrier Screening
10.3.2. Prenatal Testing
10.3.3. Preimplantation Genetic Testing
10.4. Pharmacogenomics
10.5. Infectious Disease
10.5.1. Pathogen Identification
10.5.2. Antimicrobial Resistance Profiling
10.5.3. Outbreak Surveillance
10.6. Immunology and Transplantation
10.7. Agriculture and Animal Health
10.8. Consumer Genomics and Wellness
11. Targeted Genome Analysis Kits Market, by End User
11.1. Academic and Research Institutions
11.2. Hospitals and Clinical Laboratories
11.2.1. Hospital-Based Clinical Laboratories
11.2.2. Independent Reference Laboratories
11.3. Pharmaceutical and Biotechnology Companies
11.4. Contract Research Organizations
11.5. Government and Public Health Laboratories
11.6. Direct-To-Consumer Testing Companies
11.7. Industry Quality Control and Manufacturing Laboratories
12. Targeted Genome Analysis Kits Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Targeted Genome Analysis Kits Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Targeted Genome Analysis Kits Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Targeted Genome Analysis Kits Market
16. China Targeted Genome Analysis Kits Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. 10x Genomics
17.6. Agilent Technologies, Inc.
17.7. BGI Genomics Co., Ltd.
17.8. Bio-Rad Laboratories
17.9. Eurofins Scientific SE
17.10. F. Hoffmann-La Roche Ltd.
17.11. Illumina, Inc.
17.12. Oxford Nanopore Technologies Ltd.
17.13. Pacific Biosciences of California, Inc.
17.14. PerkinElmer, Inc.
17.15. QIAGEN N.V.
17.16. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY TARGET TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY APPLICATION AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES TARGETED GENOME ANALYSIS KITS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA TARGETED GENOME ANALYSIS KITS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY TARGET TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY GERMLINE DNA, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY GERMLINE DNA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY GERMLINE DNA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SOMATIC DNA, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SOMATIC DNA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SOMATIC DNA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MITOCHONDRIAL DNA, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MITOCHONDRIAL DNA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MITOCHONDRIAL DNA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY RNA, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY RNA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY RNA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY RNA, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MRNA, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MRNA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MRNA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY NON-CODING RNA, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY NON-CODING RNA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY NON-CODING RNA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY FUSION TRANSCRIPTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY FUSION TRANSCRIPTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY FUSION TRANSCRIPTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY EPIGENETIC MARKS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY EPIGENETIC MARKS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY EPIGENETIC MARKS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY EPIGENETIC MARKS, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA METHYLATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA METHYLATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA METHYLATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY CHROMATIN ACCESSIBILITY, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY CHROMATIN ACCESSIBILITY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY CHROMATIN ACCESSIBILITY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY COMPLETE KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY COMPLETE KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY COMPLETE KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY COMPLETE KITS, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY TARGET ENRICHMENT KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY TARGET ENRICHMENT KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY TARGET ENRICHMENT KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY INTEGRATED LIBRARY AND ENRICHMENT KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY INTEGRATED LIBRARY AND ENRICHMENT KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY INTEGRATED LIBRARY AND ENRICHMENT KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PANEL-ONLY REAGENT SETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PANEL-ONLY REAGENT SETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PANEL-ONLY REAGENT SETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY ACCESSORIES AND CONTROLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY ACCESSORIES AND CONTROLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY ACCESSORIES AND CONTROLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY ACCESSORIES AND CONTROLS, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY INDEXING AND BARCODING KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY INDEXING AND BARCODING KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY INDEXING AND BARCODING KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY REFERENCE STANDARDS AND CONTROLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY REFERENCE STANDARDS AND CONTROLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY REFERENCE STANDARDS AND CONTROLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY CLEANUP AND SIZE SELECTION REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY CLEANUP AND SIZE SELECTION REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY CLEANUP AND SIZE SELECTION REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SOFTWARE AND ANALYTICS BUNDLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SOFTWARE AND ANALYTICS BUNDLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SOFTWARE AND ANALYTICS BUNDLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SOFTWARE AND ANALYTICS BUNDLES, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DATA ANALYSIS SOFTWARE LICENSES, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DATA ANALYSIS SOFTWARE LICENSES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DATA ANALYSIS SOFTWARE LICENSES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY INTERPRETATION AND REPORTING TOOLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY INTERPRETATION AND REPORTING TOOLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY INTERPRETATION AND REPORTING TOOLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY CLOUD-BASED ANALYSIS SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY CLOUD-BASED ANALYSIS SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY CLOUD-BASED ANALYSIS SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SOLID TUMOR ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SOLID TUMOR ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SOLID TUMOR ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HEMATOLOGIC ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HEMATOLOGIC ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HEMATOLOGIC ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MINIMAL RESIDUAL DISEASE MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MINIMAL RESIDUAL DISEASE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY MINIMAL RESIDUAL DISEASE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY INHERITED AND RARE DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY INHERITED AND RARE DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY INHERITED AND RARE DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY REPRODUCTIVE HEALTH, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY REPRODUCTIVE HEALTH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY REPRODUCTIVE HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY REPRODUCTIVE HEALTH, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY CARRIER SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY CARRIER SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY CARRIER SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PRENATAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PRENATAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PREIMPLANTATION GENETIC TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PREIMPLANTATION GENETIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PREIMPLANTATION GENETIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PHARMACOGENOMICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PHARMACOGENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY INFECTIOUS DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PATHOGEN IDENTIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PATHOGEN IDENTIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PATHOGEN IDENTIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY ANTIMICROBIAL RESISTANCE PROFILING, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY ANTIMICROBIAL RESISTANCE PROFILING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY ANTIMICROBIAL RESISTANCE PROFILING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY OUTBREAK SURVEILLANCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY OUTBREAK SURVEILLANCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY OUTBREAK SURVEILLANCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY IMMUNOLOGY AND TRANSPLANTATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY IMMUNOLOGY AND TRANSPLANTATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY IMMUNOLOGY AND TRANSPLANTATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY AGRICULTURE AND ANIMAL HEALTH, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY AGRICULTURE AND ANIMAL HEALTH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY AGRICULTURE AND ANIMAL HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY CONSUMER GENOMICS AND WELLNESS, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY CONSUMER GENOMICS AND WELLNESS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY CONSUMER GENOMICS AND WELLNESS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HOSPITALS AND CLINICAL LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HOSPITALS AND CLINICAL LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HOSPITALS AND CLINICAL LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HOSPITALS AND CLINICAL LABORATORIES, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HOSPITAL-BASED CLINICAL LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HOSPITAL-BASED CLINICAL LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HOSPITAL-BASED CLINICAL LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY INDEPENDENT REFERENCE LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY INDEPENDENT REFERENCE LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY INDEPENDENT REFERENCE LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY GOVERNMENT AND PUBLIC HEALTH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY GOVERNMENT AND PUBLIC HEALTH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY GOVERNMENT AND PUBLIC HEALTH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DIRECT-TO-CONSUMER TESTING COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DIRECT-TO-CONSUMER TESTING COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DIRECT-TO-CONSUMER TESTING COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY INDUSTRY QUALITY CONTROL AND MANUFACTURING LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY INDUSTRY QUALITY CONTROL AND MANUFACTURING LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY INDUSTRY QUALITY CONTROL AND MANUFACTURING LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 167. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 168. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY TARGET TYPE, 2018-2032 (USD MILLION)
TABLE 169. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA, 2018-2032 (USD MILLION)
TABLE 170. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY RNA, 2018-2032 (USD MILLION)
TABLE 171. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY EPIGENETIC MARKS, 2018-2032 (USD MILLION)
TABLE 172. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 173. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY COMPLETE KITS, 2018-2032 (USD MILLION)
TABLE 174. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY ACCESSORIES AND CONTROLS, 2018-2032 (USD MILLION)
TABLE 175. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SOFTWARE AND ANALYTICS BUNDLES, 2018-2032 (USD MILLION)
TABLE 176. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 177. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 178. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY REPRODUCTIVE HEALTH, 2018-2032 (USD MILLION)
TABLE 179. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 180. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 181. AMERICAS TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HOSPITALS AND CLINICAL LABORATORIES, 2018-2032 (USD MILLION)
TABLE 182. NORTH AMERICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. NORTH AMERICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY TARGET TYPE, 2018-2032 (USD MILLION)
TABLE 184. NORTH AMERICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA, 2018-2032 (USD MILLION)
TABLE 185. NORTH AMERICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY RNA, 2018-2032 (USD MILLION)
TABLE 186. NORTH AMERICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY EPIGENETIC MARKS, 2018-2032 (USD MILLION)
TABLE 187. NORTH AMERICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 188. NORTH AMERICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY COMPLETE KITS, 2018-2032 (USD MILLION)
TABLE 189. NORTH AMERICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY ACCESSORIES AND CONTROLS, 2018-2032 (USD MILLION)
TABLE 190. NORTH AMERICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SOFTWARE AND ANALYTICS BUNDLES, 2018-2032 (USD MILLION)
TABLE 191. NORTH AMERICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 192. NORTH AMERICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 193. NORTH AMERICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY REPRODUCTIVE HEALTH, 2018-2032 (USD MILLION)
TABLE 194. NORTH AMERICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 195. NORTH AMERICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 196. NORTH AMERICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HOSPITALS AND CLINICAL LABORATORIES, 2018-2032 (USD MILLION)
TABLE 197. LATIN AMERICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 198. LATIN AMERICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY TARGET TYPE, 2018-2032 (USD MILLION)
TABLE 199. LATIN AMERICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA, 2018-2032 (USD MILLION)
TABLE 200. LATIN AMERICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY RNA, 2018-2032 (USD MILLION)
TABLE 201. LATIN AMERICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY EPIGENETIC MARKS, 2018-2032 (USD MILLION)
TABLE 202. LATIN AMERICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 203. LATIN AMERICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY COMPLETE KITS, 2018-2032 (USD MILLION)
TABLE 204. LATIN AMERICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY ACCESSORIES AND CONTROLS, 2018-2032 (USD MILLION)
TABLE 205. LATIN AMERICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SOFTWARE AND ANALYTICS BUNDLES, 2018-2032 (USD MILLION)
TABLE 206. LATIN AMERICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 207. LATIN AMERICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 208. LATIN AMERICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY REPRODUCTIVE HEALTH, 2018-2032 (USD MILLION)
TABLE 209. LATIN AMERICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 210. LATIN AMERICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 211. LATIN AMERICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HOSPITALS AND CLINICAL LABORATORIES, 2018-2032 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY TARGET TYPE, 2018-2032 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA, 2018-2032 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY RNA, 2018-2032 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY EPIGENETIC MARKS, 2018-2032 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY COMPLETE KITS, 2018-2032 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY ACCESSORIES AND CONTROLS, 2018-2032 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SOFTWARE AND ANALYTICS BUNDLES, 2018-2032 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY REPRODUCTIVE HEALTH, 2018-2032 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HOSPITALS AND CLINICAL LABORATORIES, 2018-2032 (USD MILLION)
TABLE 227. EUROPE TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 228. EUROPE TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY TARGET TYPE, 2018-2032 (USD MILLION)
TABLE 229. EUROPE TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA, 2018-2032 (USD MILLION)
TABLE 230. EUROPE TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY RNA, 2018-2032 (USD MILLION)
TABLE 231. EUROPE TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY EPIGENETIC MARKS, 2018-2032 (USD MILLION)
TABLE 232. EUROPE TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 233. EUROPE TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY COMPLETE KITS, 2018-2032 (USD MILLION)
TABLE 234. EUROPE TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY ACCESSORIES AND CONTROLS, 2018-2032 (USD MILLION)
TABLE 235. EUROPE TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SOFTWARE AND ANALYTICS BUNDLES, 2018-2032 (USD MILLION)
TABLE 236. EUROPE TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 237. EUROPE TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 238. EUROPE TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY REPRODUCTIVE HEALTH, 2018-2032 (USD MILLION)
TABLE 239. EUROPE TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 240. EUROPE TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 241. EUROPE TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HOSPITALS AND CLINICAL LABORATORIES, 2018-2032 (USD MILLION)
TABLE 242. MIDDLE EAST TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 243. MIDDLE EAST TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY TARGET TYPE, 2018-2032 (USD MILLION)
TABLE 244. MIDDLE EAST TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA, 2018-2032 (USD MILLION)
TABLE 245. MIDDLE EAST TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY RNA, 2018-2032 (USD MILLION)
TABLE 246. MIDDLE EAST TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY EPIGENETIC MARKS, 2018-2032 (USD MILLION)
TABLE 247. MIDDLE EAST TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 248. MIDDLE EAST TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY COMPLETE KITS, 2018-2032 (USD MILLION)
TABLE 249. MIDDLE EAST TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY ACCESSORIES AND CONTROLS, 2018-2032 (USD MILLION)
TABLE 250. MIDDLE EAST TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SOFTWARE AND ANALYTICS BUNDLES, 2018-2032 (USD MILLION)
TABLE 251. MIDDLE EAST TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 252. MIDDLE EAST TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 253. MIDDLE EAST TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY REPRODUCTIVE HEALTH, 2018-2032 (USD MILLION)
TABLE 254. MIDDLE EAST TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 255. MIDDLE EAST TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 256. MIDDLE EAST TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HOSPITALS AND CLINICAL LABORATORIES, 2018-2032 (USD MILLION)
TABLE 257. AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 258. AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY TARGET TYPE, 2018-2032 (USD MILLION)
TABLE 259. AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA, 2018-2032 (USD MILLION)
TABLE 260. AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY RNA, 2018-2032 (USD MILLION)
TABLE 261. AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY EPIGENETIC MARKS, 2018-2032 (USD MILLION)
TABLE 262. AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 263. AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY COMPLETE KITS, 2018-2032 (USD MILLION)
TABLE 264. AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY ACCESSORIES AND CONTROLS, 2018-2032 (USD MILLION)
TABLE 265. AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY SOFTWARE AND ANALYTICS BUNDLES, 2018-2032 (USD MILLION)
TABLE 266. AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY APPLICATION AREA, 2018-2032 (USD MILLION)
TABLE 267. AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 268. AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY REPRODUCTIVE HEALTH, 2018-2032 (USD MILLION)
TABLE 269. AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 270. AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 271. AFRICA TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY HOSPITALS AND CLINICAL LABORATORIES, 2018-2032 (USD MILLION)
TABLE 272. ASIA-PACIFIC TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 273. ASIA-PACIFIC TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY TARGET TYPE, 2018-2032 (USD MILLION)
TABLE 274. ASIA-PACIFIC TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY DNA, 2018-2032 (USD MILLION)
TABLE 275. ASIA-PACIFIC TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY RNA, 2018-2032 (USD MILLION)
TABLE 276. ASIA-PACIFIC TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY EPIGENETIC MARKS, 2018-2032 (USD MILLION)
TABLE 277. ASIA-PACIFIC TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 278. ASIA-PACIFIC TARGETED GENOME ANALYSIS KITS MARKET SIZE, BY COM

Companies Mentioned

The key companies profiled in this Targeted Genome Analysis Kits market report include:
  • 10x Genomics
  • Agilent Technologies, Inc.
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages180
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.06 Billion
Forecasted Market Value ( USD ) by 2032 $ 4.48 Billion
Compound Annual Growth Rate6.4%
Regions CoveredGlobal
No. of Companies Mentioned13

Related Topics

Related Reports

Genome Testing Market - Global Forecast 2026-2032 - Product Image

Genome Testing Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Single-Cell Genome Sequencing Market Report 2025 - Product Image

Single-Cell Genome Sequencing Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Mutation Detection Kits In Genome Editing Market - Global Forecast 2026-2032 - Product Image

Mutation Detection Kits In Genome Editing Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Genome Sequencing Market Report 2025 - Product Image

Genome Sequencing Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Whole Genome Bisulfite Sequencing Market Size, Share & Trends Analysis Report by Product & Service (Kits & Reagents), Workflow, Application (Drug Development, Stem Cell Research), End-Use, and Region with Growth Forecasts, 2025-2030 - Product Image

Whole Genome Bisulfite Sequencing Market Size, Share & Trends Analysis Report by Product & Service (Kits & Reagents), Workflow, Application (Drug Development, Stem Cell Research), End-Use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.